NCT02449564 2018-01-17The Pilot Study Evaluate the Safety and Efficacy of Sirolimus in Patients With PIK3CA Mutation and/or PIK3CA Amplification Refractory Solid TumorsSamsung Medical CenterPhase NA Completed5 enrolled